Flt3 ligand, Recombinant, Human, aa27-184, His-Tag (Fms-related tyrosine Kinase 3 ligand, FLT3LG, Flt3L, FL, SL cytokine)
Catalog No : USB-351224
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Flt3 ligand, Recombinant, Human, aa27-184, His-Tag (Fms-related tyrosine Kinase 3 ligand, FLT3LG, Flt3L, FL, SL cytokine) | ||
|---|---|---|---|
| Catalog No | USB-351224 | ||
| Supplier’s Catalog No | 351224 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, human from insect cell line | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 19 | ||
| Storage | -20°C/-70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE) | ||
| Form | Supplied as a liquid in PBS, pH 7.4, 10% glycerol. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE) | ||
| Description | FLT3LG, also known as fms-related tyrosine kinase 3 ligand, is an alpha-cytokine that promotes the differentiation of multiple hematopoietic cell lineages. Also, this protein acts as a growth factor that increases the number of immune cells by activating the hematopoietic progenitors. FLT3LG is crucial for steady-state pDC and cDC development. It controls the development of DCs and is particularly important for plasmacytoid DCs and CD8-positive classical DCs and their CD103-positive tissue counterparts. Source: Recombinant protein corresponding to aa27-184 from human FLT3LG, fused to His-tag at C-terminal expressed in insect cell. Molecular Weight: ~19kD (166aa) AA Sequence: TQDCSFQHSP ISSDFAVKIR ELSDYLLQDY PVTVASNLQD EELCGGLWRL VLAQRWMERL KTVAGSKMQG LLERVNTEIH FVTKCAFQPP PSCLRFVQTN ISRLLQETSE QLVALKPWIT RQNFSRCLEL QCQPDSSTLP PPWSPRPLEA TAPTAPQPLE HHHHHH Endotoxin: ~1EU/1ug (LAL) Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved